Key Points
- COO Robert Ainscow sold 22,500 ASP Isotopes shares at an average price of $2.11, worth $47,475, to cover tax withholding related to vested equity awards. He retained 2,225,941 shares, a 1% reduction in his position.
- ASP Isotopes shares opened at $2.06, near the company’s 52-week low of $1.89 and well below its 52-week high of $11.22. The company recently reported an adjusted loss of $0.28 per share, missing analyst expectations, despite revenue exceeding forecasts.
- Analyst sentiment remains mixed, with an average rating of Hold and a $13 price target; 16.8% of the stock is owned by hedge funds and other institutional investors.
ASP Isotopes Inc. (NASDAQ:ASPI - Get Free Report) COO Robert Ainscow sold 22,500 shares of the firm's stock in a transaction on Wednesday, October 14th. The stock was sold at an average price of $2.11, for a total value of $47,475.00. Following the sale, the chief operating officer owned 2,225,941 shares in the company, valued at $4,696,735.51. This trade represents a 1.00% decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink. The sale was made to cover tax withholding obligations related to the vesting of equity awards.
Robert Ainscow also recently made the following trade(s):
- On Tuesday, September 8th, Robert Ainscow sold 8,438 shares of ASP Isotopes stock. The shares were sold at an average price of $4.29, for a total value of $36,199.02.
- On Wednesday, September 2nd, Robert Ainscow sold 25,000 shares of ASP Isotopes stock. The shares were sold at an average price of $3.90, for a total value of $97,500.00.
ASP Isotopes Stock Performance
ASP Isotopes stock opened at $2.06 on Tuesday. The firm has a market capitalization of $315.82 million, a P/E ratio of -1.56 and a beta of 3.69. The stock has a fifty day moving average price of $3.35 and a 200 day moving average price of $4.71. ASP Isotopes Inc. has a 52 week low of $1.89 and a 52 week high of $11.22. The company has a current ratio of 3.87, a quick ratio of 3.85 and a debt-to-equity ratio of 0.76.
ASP Isotopes (NASDAQ:ASPI - Get Free Report) last released its earnings results on Friday, August 14th. The company reported ($0.28) earnings per share for the quarter, missing the consensus estimate of ($0.17) by ($0.11). ASP Isotopes had a negative return on equity of 64.99% and a negative net margin of 427.98%. The business had revenue of $5.12 million for the quarter, compared to analysts' expectations of $4.47 million.
Institutional Trading of ASP Isotopes
Institutional investors have recently made changes to their positions in the stock. WINTON GROUP Ltd acquired a new stake in shares of ASP Isotopes during the 2nd quarter worth $588,000. Integrated Wealth Concepts LLC purchased a new position in shares of ASP Isotopes in the 2nd quarter worth $176,000. Squarepoint Ops LLC raised its position in shares of ASP Isotopes by 75.6% in the 2nd quarter. Squarepoint Ops LLC now owns 123,951 shares of the company's stock worth $771,000 after buying an additional 53,354 shares during the period. Amundi acquired a new position in ASP Isotopes in the second quarter valued at $107,000. Finally, AXQ Capital LP acquired a new position in ASP Isotopes in the second quarter valued at $80,000. 16.80% of the stock is owned by hedge funds and other institutional investors.
Wall Street Analyst Weigh In
Several research analysts have recently weighed in on ASPI shares. Wall Street Zen upgraded shares of ASP Isotopes from a "strong sell" rating to a "sell" rating in a report on Saturday, August 22nd. Weiss Ratings reissued a "sell (d-)" rating on shares of ASP Isotopes in a research report on Monday, September 21st. Two analysts have rated the stock with a Buy rating and one has assigned a Sell rating to the company. According to MarketBeat.com, the company presently has an average rating of "Hold" and an average price target of $13.00.
Read Our Latest Stock Report on ASPI
ASP Isotopes Company Profile
(
Get Free Report)
ASP Isotopes Inc (NASDAQ: ASPI) is a development-stage advanced materials company focused on isotope enrichment. The company is developing proprietary technology intended to separate and enrich isotopes for use in several high-value markets, including nuclear energy, medicine, semiconductors, quantum computing and other industrial applications.
ASP Isotopes has described its platform as being designed to provide more efficient and scalable isotope production than certain conventional enrichment methods.
See Also
This instant news alert was generated by narrative science technology and financial data from InsiderTrades.com in order to provide readers with the fastest and most accurate reporting. Please send any questions or comments about this story to [email protected].
